Abstract:<p>Salidroside (Sal) is a bioactive extract principally from traditional herbal medicine such as <em>Rhodiola rosea</em> L., which has been commonly used for hundreds of years in Asia countries. The excellent neuroprotective capacity of Sal has been illuminated in recent studies. This work focused on the source, pharmacokinetics, safety and anti-ischemic stroke (IS) effect of Sal, especially emphasizing its mechanism of action and BBB permeability. Extensive databases, including Pubmed, Web of science (WOS), Google Scholar and China National Knowledge Infrastructure (CNKI), were applied to obtain relevant online literatures. Sal exerts powerful therapeutic effects on IS in experimental models either in vitro or in vivo due to its neuroprotection, with significantly diminishing infarct size, preventing cerebral edema and improving neurological function. Also, the findings suggest the underlying mechanisms involve anti-oxidation, anti-inflammation and anti-apoptosis by regulating multiple signaling pathways and key molecules, such as NF-κB, TNF-α and PI3K/Akt pathway. In pharmacokinetics, although showing a rapid absorption and elimination, bioavailability of Sal is elevated under some non-physiological conditions. The component and its metabolite (tyrosol) are capable of distributing to brain tissue and the later keeps a higher level of concentration. Moreover, Sal scarcely has obvious toxicity or side effects in a variety of animal experiments and clinical trials, but combination of drugs and perinatal use of medicine should be taken more attentions. Finally, as an active ingredient, not only is Sal isolated from diverse plants with limited yield, but also large batches of the products can be harvested by biological and chemical synthesis. With higher efficacy and better safety profiles, Sal could sever as a promising neuroprotectant for preventing and treating IS. Nevertheless, further investigations are still required to explore the pharmacodynamic and pharmacokinetic properties of Sal in the treatment of IS.</p>

Research Progress in Pharmacokinetics of Salidroside

Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties

Pharmacokinetics, Tissue Distribution, and Excretion of Salidroside in Rats

Preparation of Salidroside Injection and Its Pharmacokinetics in Rats

The Sources of Salidroside and Its Targeting for Multiple Chronic Diseases

Biosynthesis and biotechnological production of salidroside from Rhodiola genus plants

Advances in studies of the pharmacokinetics of salvianolic acid B

Pharmacological functions of salidroside in renal diseases: facts and perspectives

Progress of Researches on Pharmacokinetics of Active Components of Chinese Drugs

Progress on the Role of Salidroside in Neurodegenerative Diseases

Mechanism of salidroside regulating autophagy based on network pharmacology and molecular docking

ESI MS and MS/MS Behavior of Salidroside and Its Esters

Estimation of extraction efficiency of salidroside from Rhodiola rosea using deep eutectic solvents

Salidroside - Can it be a Multifunctional Drug?

Comparative in vivo constituents and pharmacokinetic study in rats after oral administration of ultrafine granular powder and traditional decoction slices of Chinese Salvia

Chemical Synthesis, Experimental, Molecular Docking and Drug-likeness Studies of Salidroside

Salidroside as a potential neuroprotective agent for ischemic stroke: a review of sources, pharmacokinetics, mechanism and safety

Therapeutic potential and molecular mechanisms of salidroside in ischemic diseases

Recent developments in Salvia miltiorrhiza polysaccharides: Isolation, purification, structural characteristics and biological activities

Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage

Pharmacokinetics of Salvianolic Acid B, Rosmarinic Acid and Danshensu in Rat after Pulmonary Administration of Salvia Miltiorrhiza Polyphenolic Acid Solution